RCGP eLearning Podcast

In this 15 minute podcast, Dr Michael Mulholland, RCGP Honorary Secretary, talks to Dr Joy Shacklock, GP and RCGP Clinical Policy Representative for Safeguarding, about the new RCGP safeguarding standards. Joy explains the new document and the drivers behind the updates, as well as the supporting resources and how they can be used. In particular, she highlights the new all-age safeguarding toolkit and how to get the best out of it, along with pointers on safeguarding training and updated revalidation requirements.  This podcast was produced by RCGP Learning. Editorial and content decisions were made solely by the RCGP. 

An estimated 10 million people (6 million women, 4 million men) in the UK have osteoarthritis, with an estimated 5.4 million people affected osteoarthritis in the knee and 3.2 million in the hip. An estimated 350,000 people are diagnosed with osteoarthritis each year with a median age of symptom onset of 55 years. In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks with Dr Louise Warburton, a GP with a special interest in musculoskeletal care and rheumatology, Honorary Senior Lecturer at Keele University and Co-president of the Primary Care Rheumatology and Musculoskeletal Medicine Society, about osteoarthritis including risk factors, presentation, clinical history, examination, diagnosis and treatment/self management.  

Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP. Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most significant clinical effects are in infants and people who are elderly and have chronic medical conditions or immunosuppression. In this podcast, Professor Simon de Lusignan from the RCGP’s Research and Surveillance Centre discusses the new RSV vaccination programme, which offers a one-off vaccine to everyone at the age of 75, with an initial catch-up programme between the ages of 75 and 80. He also touches on monoclonal antibodies and antivirals, which are given in secondary care to children who are at high risk of serious complications if they contract RSV.

A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).  In this podcast Dr Thomas Round, a GP and EKU Clinical Lead, talks with Dr Nicola Weaver, a GP and Clinical Cancer Lead in Southwark, Southeast London about familial breast cancer including the recent changes to the NICE guideline.